Top compounds associated with response to LRRC37A2


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.16 5e-07
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.19 8e-07
mRNA CD-437 CTRPv2 pan-cancer AAC 0.17 9e-07
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.19 4e-06
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 9e-06
Download CSV